Related Experiment Video
Updated: Jun 20, 2026

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
Published on: August 26, 2013
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
Kai Heinecke1, Axel Seher, Werner Schmitz
1Physiologische Chemie II, Biozentrum, Universität Würzburg, Würzburg, Germany. kai.heinecke@biozentrum.uni-wuerzburg.de
Background:
Transforming growth factor (TGF)beta superfamily members transduce signals by oligomerizing two classes of serine/threonine kinase receptors, termed type I and type II. In contrast to the large number of ligands only seven type I and five type II receptors have been identified in mammals, implicating a prominent promiscuity in ligand-receptor interaction. Since a given ligand can usually interact with more than one receptor of either subtype, differences in binding affinities and specificities are likely important for the generation of distinct ligand-receptor complexes with different signaling properties.
Results:
In vitro interaction analyses showed two different prototypes of binding kinetics, 'slow on/slow off' and 'fast on/fast off'. Surprisingly, the binding specificity of ligands to the receptors of one subtype is only moderate. As suggested from the dimeric nature of the ligands, binding to immobilized receptors shows avidity due to cooperative binding caused by bivalent ligand-receptor interactions. To compare these in vitro observations to the situation in vivo, binding studies on whole cells employing homodimeric as well as heterodimeric bone morphogenetic protein 2 (BMP2) mutants were performed. Interestingly, low and high affinity binding sites were identified, as defined by the presence of either one or two BMP receptor (BMPR)-IA receptor chains, respectively. Both sites contribute to different cellular responses in that the high affinity sites allow a rapid transient response at low ligand concentrations whereas the low affinity sites facilitate sustained signaling but higher ligand concentrations are required.
Conclusion:
Binding of a ligand to a single high affinity receptor chain functioning as anchoring molecule and providing sufficient complex stability allows the subsequent formation of signaling competent complexes. Another receptor of the same subtype, and up to two receptors of the other subtype, can then be recruited. Thus, the resulting receptor arrangement can principally consist of four different receptors, which is consistent with our interaction analysis showing low ligand-receptor specificity within one subtype class. For BMP2, further complexity is added by the fact that heterooligomeric signaling complexes containing only one type I receptor chain can also be found. This indicates that despite prominent ligand receptor promiscuity a manifold of diverse signals might be generated in this receptor limited system.
Insights
Transforming growth factor-beta (TGF-β) superfamily ligands exhibit promiscuous binding to type I and type II receptors. This study reveals how ligand-receptor interactions, influenced by binding affinity and stoichiometry, generate diverse cellular signals despite limited receptor availability.
Area of Science:
- Cellular signaling
- Molecular biology
- Biochemistry
Background:
- Transforming growth factor-beta (TGF-β) superfamily ligands signal through type I and type II serine/threonine kinase receptors.
- Mammalian cells express a limited number of TGF-β receptors (7 type I, 5 type II) relative to the numerous ligands, suggesting significant ligand-receptor promiscuity.
- Variations in binding affinities and specificities are crucial for generating distinct signaling outcomes from ligand-receptor complexes.
Purpose of the Study:
- To investigate the binding kinetics and specificity of ligand-receptor interactions within the TGF-β superfamily.
- To elucidate how different binding affinities and receptor stoichiometries contribute to distinct cellular responses.
- To understand signal generation in a receptor-limited system characterized by ligand-receptor promiscuity.
Main Methods:
- In vitro interaction analyses to determine binding kinetics (e.g., 'slow on/slow off', 'fast on/fast off').
- Avidity studies using immobilized receptors to assess cooperative binding of dimeric ligands.
- In vivo binding studies on whole cells using homodimeric and heterodimeric bone morphogenetic protein 2 (BMP2) mutants to identify binding sites and affinities.
Main Results:
- Two binding kinetic prototypes were observed: 'slow on/slow off' and 'fast on/fast off'.
- Ligand binding specificity to receptors of a single subtype was only moderate, with bivalent interactions contributing to avidity.
- In vivo studies identified low and high affinity binding sites for BMP2, correlating with the presence of one or two BMP receptor (BMPR)-IA chains, respectively.
- High affinity sites mediated rapid, transient responses at low ligand concentrations, while low affinity sites supported sustained signaling at higher concentrations.
Conclusions:
- Ligand binding to a high-affinity receptor chain initiates signaling complex formation, enabling subsequent recruitment of other receptor subtypes.
- Receptor complexes can comprise up to four receptors, consistent with observed low ligand-receptor specificity within subtypes.
- Heterooligomeric signaling complexes with a single type I receptor chain are possible for BMP2, adding complexity.
- Despite ligand-receptor promiscuity, a diverse range of signals can be generated within this receptor-limited system.
More Related Videos
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Receptor Tyrosine Kinases
Bone Remodeling and Repair
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: